ENFR

Omega Pharma and Madestea

September 2004

Omega Pharma, the Belgium group listed on Euronext, has acquired Madestea, the leading cosmetics and food supplements player on the Italian OTC market under the Sant’Angelica brand.

Ohana & Co. acted as the exclusive financial advisor to Omega Pharma.


Press release

Related Transactions

Les Inrockuptibles (France), the iconic and cult news magazine covering music, entertainment and society issues, has been acquired by a holding company formed by Matthieu Pigasse, the investment fund Orium and the founder of Les Inrockuptibles. Ohana & Co. acted as the exclusive financial advisor to Les Inrockuptibles and its majority shareholder.

Read more

Ohana & Co. completed a Corporate Finance assignment for Groupe Clarins (one of the world’s leading beauty groups with brands such as Clarins and Thierry Mugler), including a strategic review of opportunities.

Read more

AREVA (EPA: AREVA), the France-based global leader in nuclear energy with 2015 sales of $4.6 billion, has sold its wholly owned US subsidiary, Canberra Industries, the leading provider of innovative nuclear measurement solutions, to California-based Mirion Technologies, a global leader in radiation detection and protection, backed by private equity fund Charterhouse Capital. Canberra Industries, based in Meriden, Connecticut, is a leader in the nuclear measurement sector. It designs, manufactures and markets innovative and cost-effective nuclear measurement solutions used to maintain safety of personnel, assess the health of nuclear facilities and safeguard the public and the environment. Canberra generated revenues of about $200 million in 2014 and has more than a thousand employees worldwide. In this competitive process initiated by Areva in June 2015, Ohana & Co. acted as global advisor to Canberra’s management team, accompanying it throughout the entire process. Ohana & Co. assisted the management team on the structuring of its exit package, the preparation of the roadshow with the various bidders and the negotiation of equity investment packages with each of the bidders shortlisted by Areva.

Read more